Single cell analysis to dissect molecular heterogeneity and disease evolution in metastatic melanoma
出版年份 2019 全文链接
标题
Single cell analysis to dissect molecular heterogeneity and disease evolution in metastatic melanoma
作者
关键词
-
出版物
Cell Death & Disease
Volume 10, Issue 11, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2019-10-31
DOI
10.1038/s41419-019-2048-5
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Integrative single-cell analysis
- (2019) Tim Stuart et al. NATURE REVIEWS GENETICS
- Distinct Immune Cell Populations Define Response to Anti-PD-1 Monotherapy and Anti-PD-1/Anti-CTLA-4 Combined Therapy
- (2019) Tuba N. Gide et al. CANCER CELL
- Many ways to resistance: How melanoma cells evade targeted therapies
- (2019) Ines Kozar et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Analysis of the Human Kinome and Phosphatome by Mass Cytometry Reveals Overexpression-Induced Effects on Cancer-Related Signaling
- (2019) Xiao-Kang Lun et al. MOLECULAR CELL
- Cell-state dynamics and therapeutic resistance in melanoma from the perspective of MITF and IFNγ pathways
- (2019) Xue Bai et al. Nature Reviews Clinical Oncology
- Comprehensive Integration of Single-Cell Data
- (2019) Tim Stuart et al. CELL
- Integrated multiomic analysis reveals comprehensive tumour heterogeneity and novel immunophenotypic classification in hepatocellular carcinomas
- (2019) Qi Zhang et al. GUT
- miRNAs as Candidate Biomarker for the Accurate Detection of Atypical Endometrial Hyperplasia/Endometrial Intraepithelial Neoplasia
- (2019) Simona Giglio et al. Frontiers in Oncology
- Toward Minimal Residual Disease-Directed Therapy in Melanoma
- (2018) Florian Rambow et al. CELL
- High-dimensional single-cell analysis predicts response to anti-PD-1 immunotherapy
- (2018) Carsten Krieg et al. NATURE MEDICINE
- Metabolic features of cancer stem cells: the emerging role of lipid metabolism
- (2018) Rita Mancini et al. ONCOGENE
- RNA-seq analysis identifies different transcriptomic types and developmental trajectories of primary melanomas
- (2018) Manfred Kunz et al. ONCOGENE
- Reprogramming miRNAs global expression orchestrates development of drug resistance in BRAF mutated melanoma
- (2018) Luigi Fattore et al. CELL DEATH AND DIFFERENTIATION
- Single-cell RNA-seq analysis identifies markers of resistance to targeted BRAF inhibitors in melanoma cell populations
- (2018) Yu-Jui Ho et al. GENOME RESEARCH
- Non-invasive detection of ctDNA reveals intratumour heterogeneity and is associated with tumour burden in gastrointestinal stromal tumour
- (2018) Heidi M Namløs et al. MOLECULAR CANCER THERAPEUTICS
- A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade
- (2018) Livnat Jerby-Arnon et al. CELL
- Evolution of Metastases in Space and Time under Immune Selection
- (2018) Mihaela Angelova et al. CELL
- Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma
- (2018) Moshe Sade-Feldman et al. CELL
- The potential of BRAF-associated non-coding RNA as a therapeutic target in melanoma
- (2018) Luigi Fattore et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Inhibition of Stearoyl-CoA desaturase 1 reverts BRAF and MEK inhibition-induced selection of cancer stem cells in BRAF-mutated melanoma
- (2018) Maria Elena Pisanu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Analysis of Single-Cell RNA-Seq Identifies Cell-Cell Communication Associated with Tumor Characteristics
- (2018) Manu P. Kumar et al. Cell Reports
- The Slow Cycling Phenotype: A Growing Problem for Treatment Resistance in Melanoma
- (2017) Antonio Ahn et al. MOLECULAR CANCER THERAPEUTICS
- Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance
- (2017) Sydney M. Shaffer et al. NATURE
- Targeted agents and immunotherapies: optimizing outcomes in melanoma
- (2017) Jason J. Luke et al. Nature Reviews Clinical Oncology
- Tumour heterogeneity and resistance to cancer therapies
- (2017) Ibiayi Dagogo-Jack et al. Nature Reviews Clinical Oncology
- Single-cell analysis resolves the cell state transition and signaling dynamics associated with melanoma drug-induced resistance
- (2017) Yapeng Su et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Selective targeting of point-mutated KRAS through artificial microRNAs
- (2017) Mario Acunzo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Intratumor and Intertumor Heterogeneity in Melanoma
- (2017) Tomasz M. Grzywa et al. Translational Oncology
- Tumor Evolution as a Therapeutic Target
- (2017) Nabil Amirouchene-Angelozzi et al. Cancer Discovery
- MicroRNAs in melanoma development and resistance to target therapy
- (2017) Luigi Fattore et al. Oncotarget
- Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma
- (2016) Willy Hugo et al. CELL
- miR-579-3p controls melanoma progression and resistance to target therapy
- (2016) Luigi Fattore et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
- (2016) I. Tirosh et al. SCIENCE
- Mapping heterogeneity in patient-derived melanoma cultures by single-cell RNA-seq
- (2016) Tobias Gerber et al. Oncotarget
- Tunable-Combinatorial Mechanisms of Acquired Resistance Limit the Efficacy of BRAF/MEK Cotargeting but Result in Melanoma Drug Addiction
- (2015) Gatien Moriceau et al. CANCER CELL
- Non-genomic and Immune Evolution of Melanoma Acquiring MAPKi Resistance
- (2015) Willy Hugo et al. CELL
- Genomic Classification of Cutaneous Melanoma
- (2015) Rehan Akbani et al. CELL
- Translational Implications of Tumor Heterogeneity
- (2015) M. Jamal-Hanjani et al. CLINICAL CANCER RESEARCH
- Toxicity of aflatoxin B1 towards the vitamin D receptor (VDR)
- (2015) Paola Costanzo et al. FOOD AND CHEMICAL TOXICOLOGY
- Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients
- (2015) Giulia Siravegna et al. NATURE MEDICINE
- Studying clonal dynamics in response to cancer therapy using high-complexity barcoding
- (2015) Hyo-eun C Bhang et al. NATURE MEDICINE
- Combination of antibodies directed against different ErbB3 surface epitopes prevents the establishment of resistance to BRAF/MEK inhibitors in melanoma
- (2015) Luigi Fattore et al. Oncotarget
- Every Cell Is Special: Genome-wide Studies Add a New Dimension to Single-Cell Biology
- (2014) Jan Philipp Junker et al. CELL
- Quantitative Single-Cell Approaches to Stem Cell Research
- (2014) Martin Etzrodt et al. Cell Stem Cell
- Circulating MMP11 and specific antibody immune response in breast and prostate cancer patients
- (2014) Giuseppe Roscilli et al. Journal of Translational Medicine
- Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma
- (2014) A. P. Patel et al. SCIENCE
- Turning Tumors into Vaccines: Co-opting the Innate Immune System
- (2013) Jasper G. van den Boorn et al. IMMUNITY
- Activation of an early feedback survival loop involving phospho-ErbB3 is a general response of melanoma cells to RAF/MEK inhibition and is abrogated by anti-ErbB3 antibodies
- (2013) Luigi Fattore et al. Journal of Translational Medicine
- Cancer Genome Landscapes
- (2013) B. Vogelstein et al. SCIENCE
- Acquired Resistance and Clonal Evolution in Melanoma during BRAF Inhibitor Therapy
- (2013) H. Shi et al. Cancer Discovery
- Cancer immunotherapy
- (2012) Thomas F. Gajewski Molecular Oncology
- Full-length mRNA-Seq from single-cell levels of RNA and individual circulating tumor cells
- (2012) Daniel Ramsköld et al. NATURE BIOTECHNOLOGY
- Differentiation and Persistence of Memory CD8+ T Cells Depend on T Cell Factor 1
- (2010) Xinyuan Zhou et al. IMMUNITY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation